Hims & Hers (HIMS) agreed to sell branded Wegovy and Ozempic directly on its platform while discontinuing most compounded GLP-1 advertising, resolving a patent lawsuit with Novo Nordisk and removing ...
Hosted on MSN
Hims & Hers stock soars. Its weight-loss drug battle with Novo Nordisk takes a surprising twist
Hims & Hers Health has sparred with Novo Nordisk for months over the Danish drugmaker’s refusal to sell weight-loss drugs on its platform, but the bitter feud appears to have reached its end. Hims ...
Add Yahoo as a preferred source to see more of our stories on Google. Hims & Hers, Ro, Novo Nordisk and Eli Lilly are all running Super Bowl ads for their weight loss medications. (Photo illustration: ...
Novo Nordisk A/S said it’s suing Hims & Hers Health Inc. for making knock-offs of its obesity medicines, even as Hims scrapped plans to sell a copycat version of the Wegovy pill. Hims is breaching the ...
The wellness platform's results arrived amid heightened legal and regulatory scrutiny over its weight-loss-drug business Hims & Hers reported quarterly results Monday after the closing bell. Shares of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results